{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:03:45Z","timestamp":1781708625656,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials and Biosystems"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbiosy.2026.100138","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:43:24Z","timestamp":1778283804000},"page":"100138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systematic biocompatibility assessment of 4-\u00b5m surface silicone implants"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7437-4523","authenticated-orcid":false,"given":"Isaac","family":"Mora-Leiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Clausen-Oreamuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yessica","family":"Elizondo Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Zamora-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso","family":"Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audry","family":"Zoncsich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Mendon\u00e7a","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"De Mezerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.bbiosy.2026.100138_bib0001","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.biomaterials.2008.04.023","article-title":"On the mechanisms of biocompatibility","volume":"29","author":"Williams","year":"2008","journal-title":"Biomaterials"},{"issue":"38","key":"10.1016\/j.bbiosy.2026.100138_bib0002","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.1016\/j.biomaterials.2014.08.035","article-title":"There is no such thing as a biocompatible material","volume":"35","author":"Williams","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122077","article-title":"The plasticity of biocompatibility","volume":"296","author":"Williams","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0005","unstructured":"FDA, 2020. \u201cSaline, silicone gel, and alternative breast implants | FDA.\u201d Accessed: Oct. 15, 2024. [Online]. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/saline-silicone-gel-and-alternative-breast-implants."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0006","unstructured":"FDA, 2023. \u201cUse of International Standard ISO 10993-1, \u2018biological evaluation of medical devices - part 1: evaluation and testing within a risk management process\u2019 | FDA.\u201d Accessed: Sep. 04, 2024. [Online]. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/use-international-standard-iso-10993-1-biological-evaluation-medical-devices-part-1-evaluation-and."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpra.2022.02.004","article-title":"History of breast implants: back to the future","volume":"32","author":"di Pompeo","year":"2022","journal-title":"JPRAS Open"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0008","unstructured":"FDA, 2024. \u201cPremarket approval (PMA).\u201d Accessed: Nov. 25, 2024. [Online]. Available: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P230005."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0009","unstructured":"FDA, 2025. \u201cLabeling for approved breast implants | FDA.\u201d Accessed: Aug. 21, 2025. [Online]. Available: https:\/\/www.fda.gov\/medical-devices\/breast-implants\/labeling-approved-breast-implants."},{"issue":"3","key":"10.1016\/j.bbiosy.2026.100138_bib0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/PRS.0000000000011370","article-title":"American Association of Plastic Surgeons consensus on breast implant-associated anaplastic large-cell lymphoma","volume":"154","author":"Clemens","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0011","unstructured":"FDA, 2025. \u201cMedical device reports of breast implant-associated anaplastic large cell lymphoma | FDA.\u201d Accessed: Aug. 21, 2025. [Online]. Available: https:\/\/www.fda.gov\/medical-devices\/breast-implants\/medical-device-reports-breast-implant-associated-anaplastic-large-cell-lymphoma."},{"issue":"9","key":"10.1016\/j.bbiosy.2026.100138_bib0012","doi-asserted-by":"crossref","first-page":"NP629","DOI":"10.1093\/asj\/sjae095","article-title":"Breast implant illness as a clinical entity: a systematic review of the literature","volume":"44","author":"Kabir","year":"2024","journal-title":"Aesthet Surg J"},{"issue":"1","key":"10.1016\/j.bbiosy.2026.100138_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103448","article-title":"Breast implant illness: is it causally related to breast implants?","volume":"23","author":"Tervaert","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.bbiosy.2026.100138_bib0014","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00266-023-03692-6","article-title":"Breast implant illness through a psychiatric lens","volume":"48","author":"Suri","year":"2024","journal-title":"Aesthetic Plast Surg"},{"issue":"11","key":"10.1016\/j.bbiosy.2026.100138_bib0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/asj\/sjz227","article-title":"Breast implant illness: how can we help?","volume":"39","author":"Mcguire","year":"2019","journal-title":"Aesthet Surg J"},{"issue":"11","key":"10.1016\/j.bbiosy.2026.100138_bib0016","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/medicina57111214","article-title":"Current challenges in breast implantation","volume":"57","author":"Pelc","year":"2021","journal-title":"Medicina"},{"issue":"7","key":"10.1016\/j.bbiosy.2026.100138_bib0017","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/asj\/sjab417","article-title":"Impact of capsulectomy type on post-explantation systemic symptom improvement: findings from the ASERF systemic symptoms in women-biospecimen analysis study: part 1","volume":"42","author":"Glicksman","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"9","key":"10.1016\/j.bbiosy.2026.100138_bib0018","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/asj\/sjac106","article-title":"Heavy metals in breast implant capsules and breast tissue: findings from the systemic symptoms in women-biospecimen analysis study: part 2","volume":"42","author":"Wixtrom","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"2","key":"10.1016\/j.bbiosy.2026.100138_bib0019","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/asj\/sjac225","article-title":"Microbes, histology, blood analysis, enterotoxins, and cytokines: findings from the ASERF systemic Symptoms in Women-biospecimen Analysis study: part 3","volume":"43","author":"Mcguire","year":"2023","journal-title":"Aesthet Surg J"},{"issue":"10","key":"10.1016\/j.bbiosy.2026.100138_bib0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/asj\/sjad098","article-title":"Longevity of post-explantation systemic symptom improvement and potential etiologies: findings from the ASERF systemic Symptoms in Women-biospecimen Analysis Study: part 4","volume":"43","author":"Glicksman","year":"2023","journal-title":"Aesthet Surg J"},{"issue":"10","key":"10.1016\/j.bbiosy.2026.100138_bib0021","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/asj\/sjae089","article-title":"Correlation between medically diagnosed anxiety and Depression disorder and self-reported breast implant illness","volume":"44","author":"Bresnick","year":"2024","journal-title":"Aesthet Surg J"},{"issue":"10","key":"10.1016\/j.bbiosy.2026.100138_bib0022","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s41551-021-00739-4","article-title":"The surface topography of silicone breast implants mediates the foreign body response in mice, rabbits and humans","volume":"5","author":"Doloff","year":"2021","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"10.1016\/j.bbiosy.2026.100138_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/asj\/sjy196","article-title":"Six-year prospective outcomes of primary breast augmentation with nano surface implants","volume":"39","author":"Quir\u00f3s","year":"2019","journal-title":"Aesthet Surg J"},{"issue":"12","key":"10.1016\/j.bbiosy.2026.100138_bib0024","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/medicina57121370","article-title":"A preliminary retrospective study to assess the short-term safety of traditional smooth or microtextured silicone gel-filled breast implants in Korea","volume":"57","author":"Han","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10.1016\/j.bbiosy.2026.100138_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00266-021-02152-3","article-title":"Four-year interim results of the safety of augmentation mammaplasty using the Motiva Ergonomix\u2122 round SilkSurface: a multicenter, retrospective study","volume":"45","author":"Hong","year":"2021","journal-title":"Aesthetic Plast Surg"},{"issue":"3","key":"10.1016\/j.bbiosy.2026.100138_bib0026","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/asj\/sjac276","article-title":"Six-year evaluation of Motiva round and Ergonomix SmoothSilk surface silicone breast implants: a two-center, two-surgeon outcome analysis of 1053 primary and secondary breast augmentations and augmentation mastopexy","volume":"43","author":"Randquist","year":"2023","journal-title":"Aesthet Surg J"},{"issue":"suppl_2","key":"10.1016\/j.bbiosy.2026.100138_bib0027","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/asj\/sjx150","article-title":"Preliminary 3-year evaluation of experience with SilkSurface and VelvetSurface Motiva silicone breast implants: a single-center experience with 5813 consecutive breast augmentation cases","volume":"38","author":"Sforza","year":"2018","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0028","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/asj\/sjae134","article-title":"The study of the safety and effectiveness of Motiva SmoothSilk silicone gel-filled breast implants in patients undergoing primary and revisional breast augmentation: three-year clinical data","volume":"44","author":"Glicksman","year":"2024","journal-title":"Aesthet Surg J"},{"issue":"5","key":"10.1016\/j.bbiosy.2026.100138_bib0029","doi-asserted-by":"crossref","first-page":"NP324","DOI":"10.1093\/asj\/sjz369","article-title":"Intra- and inter-shell roughness variability of breast implant surfaces","volume":"40","author":"Atlan","year":"2020","journal-title":"Aesthet Surg J"},{"issue":"10","key":"10.1016\/j.bbiosy.2026.100138_bib0030","doi-asserted-by":"crossref","first-page":"e2466","DOI":"10.1097\/GOX.0000000000002466","article-title":"Breast implant surfaces and their impact on current practices: where we are now and where are we going?","volume":"7","author":"Munhoz","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"2","key":"10.1016\/j.bbiosy.2026.100138_bib0031","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00266-018-1234-7","article-title":"Bacterial adhesion and biofilm formation on textured breast implant shell materials","volume":"43","author":"James","year":"2019","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0032","unstructured":"ISO, 2022. \u201cISO 10993-2:2022 - biological evaluation of medical devices \u2014 Part 2: animal welfare requirements.\u201d Accessed: Jan. 25, 2026. [Online]. Available: https:\/\/www.iso.org\/standard\/78866.html."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0033","unstructured":"ISO, 2014. \u201cISO 10993-3:2014 - biological evaluation of medical devices \u2014 Part 3: tests for genotoxicity, carcinogenicity and reproductive toxicity.\u201d Accessed: Jan. 25, 2026. [Online]. Available: https:\/\/www.iso.org\/standard\/55614.html."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0034","unstructured":"ISO, 2006. \u201cISO\/TS 10993-20:2006 - biological evaluation of medical devices \u2014 Part 20: principles and methods for immunotoxicology testing of medical devices.\u201d Accessed: Jan. 25, 2026. [Online]. Available: https:\/\/www.iso.org\/standard\/35979.html."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0035","series-title":"Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification","first-page":"699","article-title":"Combining neoplasms for evaluation of rodent carcinogenesis studies","author":"Brix","year":"2010"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0036","unstructured":"ISO, 2016. \u201cISO 10993-6:2016 - biological evaluation of medical devices \u2014 Part 6: tests for local effects after implantation.\u201d Accessed: Jan. 25, 2026. [Online]. Available: https:\/\/www.iso.org\/standard\/61089.html."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0037","first-page":"95","article-title":"Genotoxicity assessment of advanced composite material \u2013 Silicone gel-filled breast implant after radiation sterilization","volume":"583","author":"Liu","year":"2012","journal-title":"Adv Mat Res"},{"issue":"1","key":"10.1016\/j.bbiosy.2026.100138_bib0038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/mutage\/geq068","article-title":"In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models","volume":"26","author":"Kirsch-Volders","year":"2011","journal-title":"Mutagenesis"},{"issue":"1","key":"10.1016\/j.bbiosy.2026.100138_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.2860070102","article-title":"Development of a standard protocol for in vitro cytogenetic testing with Chinese hamster ovary cells: comparison of results for 22 compounds in two laboratories","volume":"7","author":"Galloway","year":"1985","journal-title":"Environ Mutagen"},{"issue":"6","key":"10.1016\/j.bbiosy.2026.100138_bib0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/0885328211426353","article-title":"Assessment of oxidative stress and chromosomal aberration inducing potential of three medical grade silicone polymer materials","volume":"27","author":"Vijayalakshmi","year":"2013","journal-title":"J Biomater Appl"},{"issue":"4","key":"10.1016\/j.bbiosy.2026.100138_bib0041","first-page":"824","article-title":"Chromosome instability; implications in cancer development, progression, and clinical outcomes","volume":"12","author":"Vishwakarma","year":"2020","journal-title":"Cancers 2020, Vol 12"},{"issue":"3","key":"10.1016\/j.bbiosy.2026.100138_bib0042","first-page":"293","article-title":"In vivo rodent erythrocyte micronucleus assay","volume":"312","author":"Hayashi","year":"1994","journal-title":"Mutat Res Environ Mutagen Relat Subj"},{"issue":"5","key":"10.1016\/j.bbiosy.2026.100138_bib0043","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.etp.2008.10.008","article-title":"Use of rasH2 transgenic mice for carcinogenesis testing of medical implants","volume":"61","author":"Palazzi","year":"2009","journal-title":"Exp Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.bbiosy.2026.100138_bib0044","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1091581820919896","article-title":"Tg.rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals: industry survey of current practices","volume":"39","author":"Bogdanffy","year":"2020","journal-title":"Int J Toxicol"},{"issue":"3","key":"10.1016\/j.bbiosy.2026.100138_bib0045","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/019262330002800320","article-title":"Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment","volume":"28","author":"Gulezian","year":"2000","journal-title":"Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.bbiosy.2026.100138_bib0046","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/01926230252824851","article-title":"The Tg rasH2 mouse in cancer hazard identification","volume":"30","author":"Morton","year":"2002","journal-title":"Toxicol Pathol"},{"issue":"4","key":"10.1016\/j.bbiosy.2026.100138_bib0047","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/019262339802600408","article-title":"Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-ha-ras gene used for six-month carcinogenicity studies","volume":"26","author":"Mitsumori","year":"1998","journal-title":"Toxicol Pathol"},{"issue":"4","key":"10.1016\/j.bbiosy.2026.100138_bib0048","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2131\/jts.33.493","article-title":"Carcinogenic comparative study on rasH2 mice produced by two breeding facilities","volume":"33","author":"Machida","year":"2008","journal-title":"J Toxicol Sci"},{"issue":"4","key":"10.1016\/j.bbiosy.2026.100138_bib0049","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0192623311436181","article-title":"Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature","volume":"40","author":"Nambiar","year":"2012","journal-title":"Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.bbiosy.2026.100138_bib0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0192623318810202","article-title":"A comparison of spontaneous tumors in tg.rasH2 mice in 26-week carcinogenicity studies conducted at a single test facility during 2004 to 2012 and 2013 to 2018","volume":"47","author":"Paranjpe","year":"2019","journal-title":"Toxicol Pathol"},{"issue":"7","key":"10.1016\/j.bbiosy.2026.100138_bib0051","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archsurg.1984.01390190081019","article-title":"The biologic basis for the clinical application of the silicones: a correlate to their biocompatibility","volume":"119","author":"Habal","year":"1984","journal-title":"Arch Surg"},{"issue":"12","key":"10.1016\/j.bbiosy.2026.100138_bib0052","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/bioengineering12121307","article-title":"Advances in silicone implants characterization: a comprehensive overview of chemical, physical and biological methods for biocompatibility assessment","volume":"12","author":"Dzobo","year":"2025","journal-title":"Bioengineering"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0053","first-page":"499","article-title":"High performance medical grade silicone elastomer","volume":"30","author":"Frisch","year":"1985","journal-title":"National SAMPE Symp Exhib (Proceed)"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0054","unstructured":"European Union, 2017. \u201cEu Mdr.\u201d Accessed: May 06, 2025. [Online]. Available: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A02017R0745-20250110."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0055","unstructured":"Therapeutic Goods Administration (TGA), 2018. \u201cProviding patient information leaflets and implant cards for medical devices.\u201d Accessed: May 06, 2025. [Online]. Available: https:\/\/www.tga.gov.au\/resources\/guidance\/providing-patient-information-leaflets-and-implant-cards-medical-devices?utm_source=chatgpt.com#purpose."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0056","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM), 2021. \u201cImplant monitoring devices.\u201d Accessed: May 06, 2025. [Online]. Available: https:\/\/ansm.sante.fr\/dossiers-thematiques\/dispositifs-de-surveillance-des-implants-mammaires."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0057","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA), 2022 \u201cNotifications related to safety measures (medical devices).\u201d Accessed: May 06, 2025. [Online]. Available: https:\/\/www.pmda.go.jp\/english\/safety\/info-services\/devices\/0007.html."},{"key":"10.1016\/j.bbiosy.2026.100138_bib0058","unstructured":"FDA, 2020. \u201cBreast implants - certain labeling recommendations to improve patient communication.\u201d Accessed: Sep. 04, 2024. [Online]. Available: https:\/\/www.fda.gov\/medical-devices\/breast-implants\/labeling-approved-breast-implants."},{"issue":"8","key":"10.1016\/j.bbiosy.2026.100138_bib0059","article-title":"Enhancing healthcare accountability for administrators: fostering transparency for patient safety and Quality enhancement","volume":"16","author":"Fukami","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0060","series-title":"Vital Directions for Health & Health Care: An Initiative of the National Academy of Medicine","first-page":"1","article-title":"Vital Directions for health & health Care: an Initiative of the National Academy of Medicine","author":"Dzau","year":"2017"},{"issue":"19","key":"10.1016\/j.bbiosy.2026.100138_bib0061","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191912037","article-title":"The \u2018transparency for safety\u2019 Triangle: developing a smart transparency framework to achieve a safety learning community","volume":"19","author":"Lindhout","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.bbiosy.2026.100138_bib0062","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/01926233221103202","article-title":"Scientific and regulatory policy committee points to consider for medical device implant site evaluation in nonclinical studies","volume":"50","author":"O\u2019Brien","year":"2022","journal-title":"Toxicol Pathol"},{"issue":"7","key":"10.1016\/j.bbiosy.2026.100138_bib0063","doi-asserted-by":"crossref","first-page":"NP782","DOI":"10.1093\/asj\/sjab051","article-title":"Particulate debris released from breast implant surfaces is highly dependent on implant type","volume":"41","author":"Hallab","year":"2021","journal-title":"Aesthet Surg J"},{"issue":"1","key":"10.1016\/j.bbiosy.2026.100138_bib0064","article-title":"Silicone implant surface roughness, friction, and wear","volume":"11","author":"Atkins","year":"2023","journal-title":"Surf Topogr"},{"issue":"5","key":"10.1016\/j.bbiosy.2026.100138_bib0065","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1177\/13506501221132897","article-title":"In vitro models of soft tissue damage by implant-associated frictional shear stresses","volume":"237","author":"Rosas","year":"2023","journal-title":"Proceed Instit Mech Eng Part J, J Eng Tribol"},{"issue":"4","key":"10.1016\/j.bbiosy.2026.100138_bib0066","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/PRS.0000000000004801","article-title":"The functional influence of breast implant outer shell morphology on bacterial attachment and growth","volume":"142","author":"Jones","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0067","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/asj\/sjaf245","article-title":"The study of the safety and effectiveness of Motiva SmoothSilk silicone gel-filled breast implants in patients undergoing primary and revisional breast augmentation: 5-year clinical data","volume":"46","author":"Glicksman","year":"2026","journal-title":"Aesthet Surg J"},{"issue":"5","key":"10.1016\/j.bbiosy.2026.100138_bib0068","doi-asserted-by":"crossref","first-page":"NP312","DOI":"10.1093\/asj\/sjab422","article-title":"A single center\u2019s clinical experience with Ergonomix breast implants","volume":"42","author":"Botti","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"6","key":"10.1016\/j.bbiosy.2026.100138_bib0069","doi-asserted-by":"crossref","first-page":"831e","DOI":"10.1097\/PRS.0000000000004367","article-title":"Motiva Ergonomix Round SilkSurface silicone breast implants: outcome analysis of 100 primary breast augmentations over 3 years and technical considerations","volume":"141","author":"Huemer","year":"2018","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.bbiosy.2026.100138_bib0070","first-page":"NP113","article-title":"Revisiting prepectoral breast augmentation: indications and refinements","volume":"39","author":"Sim","year":"2019","journal-title":"Aesthet Surg J"},{"issue":"3","key":"10.1016\/j.bbiosy.2026.100138_bib0071","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PRS.0000000000011612","article-title":"Subfascial transaxillary breast augmentation: critical evaluation of a 25-year review of 1015 consecutive cases","volume":"155","author":"Munhoz","year":"2025","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0072","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bjps.2023.10.105","article-title":"Outcome analysis and assessment of the lower pole expansion following breast augmentation with ergonomic implants: optimizing results with patient selection based on 5-year data","volume":"88","author":"Munhoz","year":"2024","journal-title":"J Plastic, Reconst Aesthetic Surg"},{"issue":"1","key":"10.1016\/j.bbiosy.2026.100138_bib0073","doi-asserted-by":"crossref","first-page":"29e","DOI":"10.1097\/PRS.0000000000010196","article-title":"Hybrid augmentation mastopexy with new generation of smooth surface implants: combining the benefits of fat grafting, inferior muscle support, and an l-shaped scar","volume":"152","author":"Munhoz","year":"2023","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bbiosy.2026.100138_bib0074","unstructured":"Establishment Labs Holdings Inc, 2025. \u201cEstablishment Labs Holdings Corp. - Establishment Labs publishes 15 years of Motiva data in 2025 post-market surveillance report.\u201d Accessed: Oct. 09, 2025. [Online]. Available: https:\/\/investors.establishmentlabs.com\/press-releases\/press-releases-details\/2025\/Establishment-Labs-Publishes-15-Years-of-Motiva-Data-in-2025-Post-Market-Surveillance-Report\/default.aspx."}],"container-title":["Biomaterials and Biosystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666534426000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666534426000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:48:20Z","timestamp":1781707700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666534426000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"alternative-id":["S2666534426000127"],"URL":"https:\/\/doi.org\/10.1016\/j.bbiosy.2026.100138","relation":{},"ISSN":["2666-5344"],"issn-type":[{"value":"2666-5344","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic biocompatibility assessment of 4-\u00b5m surface silicone implants","name":"articletitle","label":"Article Title"},{"value":"Biomaterials and Biosystems","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbiosy.2026.100138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100138"}}